NVT Northern Venture Trust PLC

Non-Executive Director Appointment

Non-Executive Director Appointment

21 AUGUST 2024

NORTHERN VENTURE TRUST PLC

NON-EXECUTIVE DIRECTOR APPOINTMENT

Northern Venture Trust PLC (“the Company”) is pleased to announce that it has appointed John E Milad to the board as a non-executive director and as a member of the Company’s audit, nomination and management engagement committees with immediate effect.

John brings over 25 years’ experience as an executive leader, board member, venture capital investor and investment banker focussed on the life sciences and medical technology sectors. He is currently the CEO of ERS Genomics, a licenser of the Nobel Prize-winning CRISPR/Cas9 gene editing technology.

Previously, John was co-founder and CEO of Quanta Dialysis Technologies, leading the development and commercial launch of a portable hemodialysis system. Prior to this, he served as CFO of Nitec Pharma, transitioning the company from development to commercial stage.

John is also an experienced venture investor, with previous roles as Partner and co-Head of Healthcare Ventures at Downing LLP and Investment Director at NBGI Ventures. Before that, he worked at Atlas Venture and Kirkland Investors.

John currently serves as a Trustee on the Board of Kidney Research UK and is a business mentor at the Royal Academy of Engineering’s accelerator program.

There are no disclosures to be made in accordance with UKLR 6.4.8 R of the UK Listing Rules in relation to John E Milad’s appointment.

Enquiries:

Sarah Williams / James Sly, Mercia Fund Management Limited - 0330 223 1430

Website:

Neither the contents of the Mercia Asset Management PLC website, nor the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website), are incorporated into, or form part of, this announcement.



EN
21/08/2024

Underlying

NVTNorthern Venture Trust PLC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Northern Venture Trust PLC

 PRESS RELEASE
Free
NVT Northern Ventur...

Half-yearly report

Half-yearly report 21 NOVEMBER 2024 NORTHERN VENTURE TRUST PLC HALF-YEARLY REPORT A copy of Northern Venture Trust PLC’s unaudited half-yearly report for the six months ended 30 September 2024 has been submitted to the National Storage Mechanism. A copy of the report is also available on the Mercia website at    Enquiries: Sarah Williams / James Sly, Mercia Fund Management Limited - 0330 223 1430 Website: Neither the contents of the Mercia Asset Management PLC website, nor the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any oth...

November 21, 2024 1 EN
 PRESS RELEASE
Free
NVT Northern Ventur...

Dividend Declaration

Dividend Declaration 21 NOVEMBER 2024 NORTHERN VENTURE TRUST PLC DIVIDEND DECLARATION Northern Venture Trust PLC (“the Company”) is pleased to declare an interim dividend of 1.6 pence per ordinary share in respect of the year ending 31 March 2025. The interim dividend will be paid on 22 January 2025 to shareholders on the register on 20 December 2024. The ex-dividend date is 19 December 2024. The Company’s dividend investment scheme, which enables shareholders to invest their dividends in new ordinary shares free of dealing costs and with the benefit of the tax reliefs available on ne...

November 21, 2024 1 EN
 PRESS RELEASE
Free
NVT Northern Ventur...

Unaudited Half-Yearly Financial Report for the Six Months Ended 30 Sep...

Unaudited Half-Yearly Financial Report for the Six Months Ended 30 September 2024 21 NOVEMBER 2024 NORTHERN VENTURE TRUST PLC UNAUDITED HALF-YEARLY FINANCIAL REPORTFOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024 Northern Venture Trust PLC is a Venture Capital Trust (VCT) whose investment adviser is Mercia Fund Management Limited. The trust was one of the first VCTs launched on the London Stock Exchange in 1995. It invests mainly in unquoted venture capital holdings and aims to provide long-term tax-free returns to shareholders through a combination of dividend yield and capital growth. Finan...

November 21, 2024 1 EN
 PRESS RELEASE
Free
NVT Northern Ventur...

Total voting rights

Total voting rights 31 OCTOBER 2024 NORTHERN VENTURE TRUST PLC TOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern Venture Trust PLC (“the Company”) notifies the market that the capital of the Company as at 31 October 2024 consists of 199,158,435 ordinary shares with a nominal value of 25p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 199,158,435 (“the Figure”). The Figure may be...

October 31, 2024 1 EN
 PRESS RELEASE
Free
NVT Northern Ventur...

Total voting rights

Total voting rights 30 SEPTEMBER 2024 NORTHERN VENTURE TRUST PLC TOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern Venture Trust PLC (“the Company”) notifies the market that the capital of the Company as at 30 September 2024 consists of 199,158,435 ordinary shares with a nominal value of 25p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 199,158,435 (“the Figure”). The Figure ma...

September 30, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch